These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 9345025)
1. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025 [TBL] [Abstract][Full Text] [Related]
2. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761 [TBL] [Abstract][Full Text] [Related]
3. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production. Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584 [TBL] [Abstract][Full Text] [Related]
4. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234 [TBL] [Abstract][Full Text] [Related]
5. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458 [TBL] [Abstract][Full Text] [Related]
6. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080 [TBL] [Abstract][Full Text] [Related]
7. IL-3 does not contribute to platelet production in c-Mpl-deficient mice. Chen Q; Solar G; Eaton DL; de Sauvage FJ Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175 [TBL] [Abstract][Full Text] [Related]
8. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo. Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229 [TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia in c-mpl-deficient mice. Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287 [TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921 [TBL] [Abstract][Full Text] [Related]
11. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Vyas P; Ault K; Jackson CW; Orkin SH; Shivdasani RA Blood; 1999 May; 93(9):2867-75. PubMed ID: 10216081 [TBL] [Abstract][Full Text] [Related]
12. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Li J; Xia Y; Kuter DJ Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590 [TBL] [Abstract][Full Text] [Related]
13. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799 [TBL] [Abstract][Full Text] [Related]
14. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of thrombopoietin receptors on human megakaryocytes. Kuwaki T; Hagiwara T; Yuki C; Kodama I; Kato T; Miyazaki H FEBS Lett; 1998 May; 427(1):46-50. PubMed ID: 9613597 [TBL] [Abstract][Full Text] [Related]
16. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. de Sauvage FJ; Carver-Moore K; Luoh SM; Ryan A; Dowd M; Eaton DL; Moore MW J Exp Med; 1996 Feb; 183(2):651-6. PubMed ID: 8627177 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice. Shivdasani RA; Fielder P; Keller GA; Orkin SH; de Sauvage FJ Blood; 1997 Sep; 90(5):1821-7. PubMed ID: 9292514 [TBL] [Abstract][Full Text] [Related]
18. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling. Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013 [TBL] [Abstract][Full Text] [Related]
19. Hematopoietic deficiencies in c-mpl and TPO knockout mice. Murone M; Carpenter DA; de Sauvage FJ Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742 [TBL] [Abstract][Full Text] [Related]
20. c-mpl, the thrombopoietin receptor. Vainchenker W; Methia N; Debili N; Titeux M; Wendling F Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]